Thrombolysis has been the mainstay of reperfusion therapy for ischemic stroke for 30 years. Alteplase, a recombinant form of tissue plasminogen activator, has been the sole thrombolytic treatment ...

When blood clots block your blood vessels, it is called thrombosis. Symptoms vary based on the blood clot location, but can include shortness of breath, chest pain, difficulty speaking, or vision ...

A clot-dissolving tissue plasminogen activator (tPA), tenecteplase is now indicated ... Tenecteplase thus officially joins the other stroke thrombolytic approved stateside, alteplase (Activase ...

In the European approval of rtPA for stroke treatment, any anticoagulation at the time of planned treatment is considered a strict contraindication to thrombolysis, whereas under US license ...

Plasduce Mbossa, the Tanzania Ports Authority (TPA) general manager, made this affirmation when speaking to journalists here yesterday port sector activities in the past four years, noting that MoUs ...

Forbes contributors publish independent expert analyses and insights. I’m an ER doc, public health researcher and patient advocate.

Just hours ahead of the Spurs' home game against the Suns, the team announced that Wembanyama had been diagnosed with deep vein thrombosis in his right shoulder. The condition would force ...

Background: Thrombolysis with tissue plasminogen activator (tPA) remains the only approved drug therapy for acute ischemic stroke. However, delayed tPA treatment is associated with an increased risk ...

VTE, which includes deep vein thrombosis (DVT) and pulmonary embolism (PE), and the subsequent complications of post-thrombotic syndrome (PTS), are significant causes of morbidity and mortality in ...

These findings coupled with his ongoing hemolysis were suggestive of likely device thrombosis. The patient was initially ... antiplatelet therapy (intravenous eptifibatide), and TPA, tissue-type ...